Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky et al. · New England Journal of Medicine · 2016 · 2K citations · Full text

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham et al. · The Lancet · 2017 · 1.2K citations · Full text

Allergy, Atopic Dermatitis, Allergy Medicine +8

Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch

Landon K. Oetjen, Madison R. Mack, Jing Feng et al. · Cell · 2017 · 996 citations · Full text

Autoimmune Disease, Sensory Neuroscience, Medicine +14

Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition

Luzhou Xing, Zhenpeng Dai, Ali Jabbari et al. · Nature Medicine · 2014 · 916 citations · Full text

Cytotoxic T Lymphocytes, Autoimmune Disease, Scleroderma +13

TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation

Brian Kim, Mark C. Siracusa, Steven A. Saenz et al. · Science Translational Medicine · 2013 · 706 citations